Table 3.

—Spearman Correlation Coefficients Between SGRQ Change Scores and Anchor Change Scores From Baseline to 6 and 12 Months

Domain	Symptom	Activity	Impact	Total
FEV1%
6 mo	−0.18 (.09)	−0.34 (.0016)	−0.37 (.0005)	−0.42 (< .0001)
12 mo	−0.16 (.18)	−0.16 (.1621)	−0.24 (.0378)	−0.27 (.0204)
Dlco%
6 mo	−0.02 (.83)	0.07 (.51)	−0.08 (.46)	−0.05 (.65)
12 mo	−0.04 (.76)	−0.11 (.32)	−0.05 (.66)	−0.08 (.52)
6MWD
6 mo	−0.07 (.51)	−0.17 (.1181)	−0.15 (.18)	−0.18 (.1128)
12 mo	−0.22 (.06)	−0.30 (.0086)	−0.22 (.06)	−0.35 (.0023)
Log(VEGF-D)
6 mo	0.06 (.63)	0.09 (.45)	0.19 (.09)	0.20 (.09)
12 mo	0.10 (.39)	0.15 (.23)	0.09 (.46)	0.15 (.23)

Values are Spearman correlation coefficients (P value). See Table 1 legend for expansion of abbreviations.